Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients

Our objective was to determine whether the presence of the human leukocyte antigen HLA-DRB1 locus is associated with production of anti-cyclic citrullinated peptide antibodies (anti-CCP Abs) and to what extent they are associated with increased susceptibility to and severity of rheumatoid arthritis...

Full description

Bibliographic Details
Main Authors: H.M. Farouk, H.E. Mansour, S.A. Rahman, A.A. Mostafa, H.A. Shamy, W.A. Zarouk
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2009-09-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000900010
_version_ 1818579110383845376
author H.M. Farouk
H.E. Mansour
S.A. Rahman
A.A. Mostafa
H.A. Shamy
W.A. Zarouk
author_facet H.M. Farouk
H.E. Mansour
S.A. Rahman
A.A. Mostafa
H.A. Shamy
W.A. Zarouk
author_sort H.M. Farouk
collection DOAJ
description Our objective was to determine whether the presence of the human leukocyte antigen HLA-DRB1 locus is associated with production of anti-cyclic citrullinated peptide antibodies (anti-CCP Abs) and to what extent they are associated with increased susceptibility to and severity of rheumatoid arthritis (RA) in Egyptian patients. Twenty-nine RA patients gave informed consent to participate in a case-control study that was approved by the Ain Shams University Medical Ethics Committee. RA disease activity and severity were determined using the simplified disease activity index and Larsen scores, respectively. We used a wide scale national study on the pattern of HLA typing in normal Egyptians as a control study. Anti-CCP Abs and HLA-DRB1 typing were determined for all subjects. The alleles most strongly associated with RA were HLA-DRB1 [*01 , *04 and *06] (41.4%). RA patients with serum anti-CCP Ab titers above 60 U/mL had a significantly higher frequency of HLA-DRB1*01 (58.3%) and HLA-DRB1*04 alleles (83.3%). Significant positive correlations were found between serum and synovial anti-CCP Ab titer, RA disease activity, and severity (r = 0.87, 0.66 and 0.63, respectively; P < 0.05). HLA-DRB1 SE+ alleles [*01 and *04] were highly expressed among Egyptian RA patients. The presence of these alleles was associated with higher anti-CCP Ab titer, active and severe RA disease. Early determination of HLA-DRB1 SE+ alleles and serum anti-CCP Ab could facilitate the prediction of the clinical course and prognosis of RA when first evaluated leading to better disease control.
first_indexed 2024-12-16T06:56:29Z
format Article
id doaj.art-b7cd536305b14e93a936343794343e02
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-16T06:56:29Z
publishDate 2009-09-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-b7cd536305b14e93a936343794343e022022-12-21T22:40:16ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2009-09-0142983183810.1590/S0100-879X2009000900010Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patientsH.M. FaroukH.E. MansourS.A. RahmanA.A. MostafaH.A. ShamyW.A. ZaroukOur objective was to determine whether the presence of the human leukocyte antigen HLA-DRB1 locus is associated with production of anti-cyclic citrullinated peptide antibodies (anti-CCP Abs) and to what extent they are associated with increased susceptibility to and severity of rheumatoid arthritis (RA) in Egyptian patients. Twenty-nine RA patients gave informed consent to participate in a case-control study that was approved by the Ain Shams University Medical Ethics Committee. RA disease activity and severity were determined using the simplified disease activity index and Larsen scores, respectively. We used a wide scale national study on the pattern of HLA typing in normal Egyptians as a control study. Anti-CCP Abs and HLA-DRB1 typing were determined for all subjects. The alleles most strongly associated with RA were HLA-DRB1 [*01 , *04 and *06] (41.4%). RA patients with serum anti-CCP Ab titers above 60 U/mL had a significantly higher frequency of HLA-DRB1*01 (58.3%) and HLA-DRB1*04 alleles (83.3%). Significant positive correlations were found between serum and synovial anti-CCP Ab titer, RA disease activity, and severity (r = 0.87, 0.66 and 0.63, respectively; P < 0.05). HLA-DRB1 SE+ alleles [*01 and *04] were highly expressed among Egyptian RA patients. The presence of these alleles was associated with higher anti-CCP Ab titer, active and severe RA disease. Early determination of HLA-DRB1 SE+ alleles and serum anti-CCP Ab could facilitate the prediction of the clinical course and prognosis of RA when first evaluated leading to better disease control.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000900010HLA-DRB1Anti-CCP AbRheumatoid arthritis
spellingShingle H.M. Farouk
H.E. Mansour
S.A. Rahman
A.A. Mostafa
H.A. Shamy
W.A. Zarouk
Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
Brazilian Journal of Medical and Biological Research
HLA-DRB1
Anti-CCP Ab
Rheumatoid arthritis
title Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
title_full Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
title_fullStr Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
title_full_unstemmed Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
title_short Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
title_sort effect of the human leukocyte antigen hla drb1 and anti cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
topic HLA-DRB1
Anti-CCP Ab
Rheumatoid arthritis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000900010
work_keys_str_mv AT hmfarouk effectofthehumanleukocyteantigenhladrb1andanticycliccitrullinatedpeptideontheoutcomeofrheumatoidarthritispatients
AT hemansour effectofthehumanleukocyteantigenhladrb1andanticycliccitrullinatedpeptideontheoutcomeofrheumatoidarthritispatients
AT sarahman effectofthehumanleukocyteantigenhladrb1andanticycliccitrullinatedpeptideontheoutcomeofrheumatoidarthritispatients
AT aamostafa effectofthehumanleukocyteantigenhladrb1andanticycliccitrullinatedpeptideontheoutcomeofrheumatoidarthritispatients
AT hashamy effectofthehumanleukocyteantigenhladrb1andanticycliccitrullinatedpeptideontheoutcomeofrheumatoidarthritispatients
AT wazarouk effectofthehumanleukocyteantigenhladrb1andanticycliccitrullinatedpeptideontheoutcomeofrheumatoidarthritispatients